Treatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D. Preliminary observations.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000532:radiotherapy*; D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D003036:Cobalt Isotopes / Q000627:therapeutic use; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use*; D004806:Ependymoma / Q000188:drug therapy / Q000532:radiotherapy; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D006393:Hemangiopericytoma / Q000188:drug therapy / Q000532:radiotherapy; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007263:Infusions, Parenteral; D008080:Liposarcoma / Q000188:drug therapy / Q000532:radiotherapy; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008637:Mesenchymoma / Q000188:drug therapy / Q000532:radiotherapy; D012516:Osteosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D012189:Retrospective Studies; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy; D012509:Sarcoma / Q000188:drug therapy* / Q000532:radiotherapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000532:radiotherapy; D013584:Sarcoma, Synovial / Q000188:drug therapy / Q000532:radiotherapy; D013724:Teratoma / Q000188:drug therapy
D003036:Cobalt Isotopes; D003609:Dactinomycin